Skip to content

PP&E (Net) at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$142.4M+38.4%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$4.94M-26.2%
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
$8.04M+323%
AbbVie logo
AbbVieABBV
$5.69B+8.6%
Revvity logo
RevvityRVTY
$465.64M-4.3%
ALN
Alnylam PharmaceuticalsALNY

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$11.52B+402%
Enterprise value$11.44B+418%
P/S18.5×+14.3×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Reported directly by Arrowhead Research in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Arrowhead Research’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arrowhead Research's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arrowhead Research's PP&E (net)?
Arrowhead Research (ARWR) reported PP&E (net) of $374.82M in Q1 2026.
How has Arrowhead Research's PP&E (net) changed year-over-year?
Arrowhead Research's PP&E (net) decreased by 2.6% year-over-year, from $384.8M to $374.82M.
What is the long-term trend for Arrowhead Research's PP&E (net)?
Over 5 years (2020 to 2025), Arrowhead Research's PP&E (net) has grown at a 65.4% compound annual growth rate (CAGR), from $30.88M to $382.52M.
What does PP&E (net) mean?
The value of physical assets like lab equipment and buildings, minus depreciation.
How do you interpret PP&E (net)?
An increase reflects capital investment in research capabilities, while a decrease may indicate asset aging or divestment.
How does PP&E (net) compare across companies?
Varies based on whether the company owns its lab facilities or utilizes contract research organizations (CROs) and leased space.